Daunorubicin

From WikiMD.org
Jump to navigation Jump to search

Daunorubicin

Daunorubicin (pronounced: daw-no-ru-bi-sin), also known as daunomycin, is a chemotherapy drug used in the treatment of certain types of cancer. It belongs to the family of drugs known as anthracyclines.

Etymology

The name "Daunorubicin" is derived from the bacterium Streptomyces peucetius var. caesius, from which it was first isolated in the 1960s. The bacterium was named after the Italian city of Daunia, where it was first discovered.

Usage

Daunorubicin is used primarily in the treatment of leukemia, specifically acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML). It works by interfering with the growth of cancer cells, which eventually leads to their destruction.

Related Terms

  • Chemotherapy: A type of cancer treatment that uses drugs to destroy cancer cells.
  • Anthracyclines: A class of drugs used in cancer chemotherapy that are made from certain types of bacteria.
  • Leukemia: A type of cancer of the blood or bone marrow characterized by an abnormal increase in white blood cells.
  • Acute lymphoblastic leukemia (ALL): A type of leukemia that starts from white blood cells in the bone marrow, the soft inner part of bones.
  • Acute myeloid leukemia (AML): A type of leukemia that starts in the bone marrow (the soft inner part of certain bones, where new blood cells are made), but in most cases it quickly moves into the blood.

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski